ClinicalTrials.Veeva

Menu

Evaluation of an Integrative Medicine Outpatient Clinical Setting for Post-COVID-19 Patients (TaPoCo)

U

Universität Duisburg-Essen

Status

Completed

Conditions

COVID-19
Fatigue

Treatments

Other: waiting group
Behavioral: outpatient clinic with multimodal integrative medicine and naturopathy for post-COVID-19 patients

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The study aims to identify whether a multimodal integrative naturopathy outpatient clinical concept can improve the symptoms of patients suffering from post-COVID-Syndrome. Main outcome is fatigue. The outpatient clinical programme consists of 11 weeks wherein patients visit the clinic one day per week. The pillars of classical naturopathy are combined with extended naturopathy and complementary procedures. Previous naturopathical studies on patients with chronic fatigue syndrome could find numerous indications that different types of naturopathy can help patients with fatigue.

Enrollment

42 patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 18 to 75 years of age
  • diagnosed with post covid syndrome
  • fatigue with or without myalgia
  • signed declaration of consent

Exclusion criteria

  • contraindications for whole body infrared hyperthermia (severe cardiovascular diseases, tumour diseases, acute infections, pregnant and breastfeeding women)
  • Acute and or feverish microbially infections
  • Pleuritic chest pain
  • Relevant shortness of breath
  • Zn Critical illness or intensive medical care because of COVID 19
  • Patients with severe somatic, cardiovascular pneumological, rheumatic, endocrine or neurological comorbidities. Especially neurological disorders accompanied by cognitive impairment, severe liver or kidney disorders.
  • Patients permanently treated with opioids, cannabis, immunosuppressive agents (e.g. corticoids, immunsuppressives) or alpha/beta-a(nta)gonists
  • Patients with pain as a consequence of a severe psychiatric disease (bipolar disorder, psychosis, personality disorder, severe depression, substance abuse) as well as severe systematic disorders or neurological disorders
  • Participation in other clinical studies

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

42 participants in 2 patient groups

Treatment group
Experimental group
Description:
The treatment group has 11 visits in the outpatient clinic of integrative medicine and naturopathy. Additional they fill in a diary and wear a pedometer during the day. Diary and pedometer continue to week 15. In week 12 a video conference with the treatment-group takes place. During week 14+15 a qualitative telephone interview is set. Patients fill in questionnaires before the start of the outpatient clinic and directly afterwards (week 11).
Treatment:
Behavioral: outpatient clinic with multimodal integrative medicine and naturopathy for post-COVID-19 patients
Waiting group
Other group
Description:
Parallel to the treatment group the waiting group receives no intervention, but fills in a diary and wear a pedometer during the day. Their diary and pedometer continue only to week 11. No additional interventions (refresher; video conference; interview) take place. Patients fill in questionnaires before the start of the waiting phase, parallel to the start of the outpatient clinic and directly after its end (week 11).
Treatment:
Other: waiting group

Trial contacts and locations

1

Loading...

Central trial contact

Sarah Schmid, Dr.; Jost Langhorst, Prof.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems